Scientists test nasal spray to fight Alzheimer's
NCT ID NCT07457125
Summary
This early-stage study is testing the safety and initial effectiveness of a nasal spray containing tiny particles (exosomes) from umbilical cord stem cells for people with mild to moderate Alzheimer's disease. The spray is given twice a week for 12 weeks. The goal is to see if the treatment is safe and if it might help slow the decline in memory and thinking skills.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD TO MODERATE ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xuanwu Hospital, Capital Medical University
Beijing, 100053, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.